arrow
A

Alison Delaney

Sheffield Teaching Hospital
H指数:3
被引数:53

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma

早期PET反应预测大B细胞淋巴瘤患者接受2线axi-cel治疗后复发的风险

2026-03-310
OAAI
Bridging practices prior to brexucabtagene autoleucel for mantle cell lymphoma in the United Kingdom: An analysis of modality, response, toxicity and survival

英国 mantle cell lymphoma 患者接受 brexucabtagene autoleucel 治疗前的过渡治疗实践:对治疗模式、疗效、毒性和生存的分析

2026-03-080
OA
Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UK

英国大型B细胞淋巴瘤患者接受二线阿西替尼西洛鲁塞注射液治疗的结局

2026-02-190
OAAI
Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in the United Kingdom: A real-world intention-to-treat analysis
2024-06-133
OAAI